Adiponectin: A Predictor for Breast Cancer Survival?

Journal: European journal of breast health
Published Date: Dec 19, 2018

Abstract

OBJECTIVE: Breast cancers in women with low serum adiponectin levels have been reported to show phenotypes that are more aggressive. In 2008, we investigated the relationship between serum adiponectin levels and breast cancer in our case-controlled study involving 83 patients, in which serum adiponectin levels were measured preoperatively. In this study, we aimed to investigate the relationship between serum adiponectin levels and breast cancer-specific survival among these 83 patients.

Authors

  • Hikmet Erhan Güven
    Department of General Surgery, University of Health Sciences, Gülhane Training and Research Hospital, Ankara, Turkey.
  • Lütfi Doğan
    Department of General Surgery, University of Health Sciences, Ankara Oncology Training and Research Hospital, Ankara, Turkey.
  • Mehmet Ali Gülçelik
    Department of General Surgery, University of Health Sciences, Gülhane Training and Research Hospital, Ankara, Turkey.
  • Neşe Ersöz Gülçelik
    Department of Endocrinology and Metabolism, University of Health Sciences, Gülhane Training and Research Hospital, Ankara, Turkey.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals